Dong-A, GSK unable to agree on product swap

Dong-A Pharmaceutical and GlaxoSmithKline (GSK), the world’s third largest pharmaceutical firm by revenue, are said to end their negotiations to exchange their healthcare products, such as Polident, Sensodyne and Garglin without agreement, according to market watchers.

So far, both companies have continued their negotiations aimed at setting the date on ways to boost their sales.

"The neg...